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Abstract
Background and aims: To report our experience and review the literature of thyroid cancer
obstructing the great veins in the neck, highlighting clinical aspects and response to treatment.
Methods: Clinical data were collected from the thyroid cancer register and from follow-up clinic
visits of patients referred to the Thyroid Unit at the Royal Marsden Hospital. A Medline literature
search was conducted between 1980 and 2007.
Results: Of 1448 patients with thyroid cancer on our cancer register and treated in our unit over
the last 60 years, we identified five patients, four women and one man, aged 43 – 81 years with a
median follow up of 28 (24–78) months in whom tumour had occluded the great veins in the neck.
All patients underwent total thyroidectomy and all subsequently received ablative 131I with the
exception of patient 3 whose post-operative isotope scan shown no significant 131I uptake. External
beam radiotherapy to the neck and upper mediastinum was used for residual disease control in the
5 patients. The median survival was 28 months and the disease-free survival was 24 months. One
patient remains asymptomatic but with disease 53 months after initial presentation. Survival in this
small series is significantly better than that previously reported for this condition.
Conclusion: A multimodality therapeutic approach comprising surgery, radioiodine and external
beam radiotherapy may give the best results for patients in whom thyroid cancer is occluding the
great veins.
Background
Microscopic vascular invasion is well recognized in thy-
roid cancer particularly in the follicular and poorly differ-
entiated histological types [1]. However massive invasion
of tumour into the great veins or external compression of
the superior vena cava is rare. Only 24 cases have been
documented in the literature (Table 1). Management of
these patients is challenging as they typically present with
advanced and rapidly progressive disease [2,3]. We identi-
fied five patients from our thyroid cancer register with
occlusion of the great veins by tumour who were managed
at our centre. Clinical features, management and outcome
of intervention are presented here together with a review
of the literature.
Materials and methods
The Royal Marsden Hospital serves as a tertiary referral
unit for patients with thyroid disease and maintains a
Published: 3 April 2008
World Journal of Surgical Oncology 2008, 6:36 doi:10.1186/1477-7819-6-36
Received: 28 December 2007
Accepted: 3 April 2008
This article is available from: http://www.wjso.com/content/6/1/36
© 2008 Hyer et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.World Journal of Surgical Oncology 2008, 6:36 http://www.wjso.com/content/6/1/36
Page 2 of 10
(page number not for citation purposes)
Table 1: Reported cases of invasion or occlusion of great veins by thyroid cancer since 1930
Study Gender Age Signs SVCO/
dilated veins
Diagnosis Pathology Extension Treatment Outcome
Wylegschanin 
(1930) [17]
F 52 Yes At autopsy Follicular cell 
carcinoma
JV, BV, SVC, RA Died 2 months
Holt (1934) [5] M 72 Yes At autopsy Adeno-
carcinoma
JV, BV, SCV Died 5 days
Mencarelli 
(1934) [17]
M 56 Yes At autopsy Anaplastic 
carcinoma
JV, RV Sudden death
Kim (1966) [6] M 64 Yes At autopsy Follicular cell 
carcinoma
JV, BV, SVC, RA Died 18 days
Muta (1977) [7] F 37 No At surgery Papillary cell 
carcinoma
BV Thrombectomy Not reported
Thompson 
(1978) [8]
F 67 Yes Venography Follicular cell 
carcinoma
JV, BV, SVC, RA Thrombectomy Alive 24 months
Perez (1984) [9] F 48 No Venography, CT Follicular cell 
carcinoma
JV, BV, SVC Thrombectomy Alive 4 months 
with metastases
Sirota (1989) 
[10]
F 61 Yes At autopsy Papillary cell 
carcinoma
AV EBRT, 131I Died 8 months
Niderle (1990) 
[11]
M 57 Yes Venography, CT Follicular cell 
carcinoma
JV, BV, SVC, RA Thrombectomy Died 13 months
Thomas (1991) 
[12 ]
M 61 Yes CT Thyroid cancer 
(unspecified)
JV Sudden death
Lalak (1997) 
[13]
F 68 No At surgery Follicular cell 
carcinoma
JV Thrombectomy 
segmental 
resection JV
Alive 9 months
Patel (1997) [2] F 79 Yes CT Papillary cell 
carcinoma
JV, SVC, BV, PV Thrombectomy 
resection JV
Died 
postoperatively 
Day 12
Onaran (1998) 
[14]
M 48 No CT Hurthle cell 
carcinoma
JV, SCV Thrombectomy 
Segmental 
resection JV
Died 12 months
F 48 No Ultrasound Papillary cell 
carcinoma
JV Segmental 
resection JV
Alive 37 months
F 68 No At surgery Hurthle cell 
carcinoma
JV Segmental 
resection JV
Alive over 36 
months
Bussani (1999) 
[15]
F 67 Yes At autopsy Follicular cell 
carcinoma
JV EBRT Died 4 months
Wiseman 
(2000) [16]
M 84 No CT Thyroid cancer 
(unspecified)
JV, BV, SVC, RA 131I Died 12 months
Mishra (2001) 
[3]
F 30 No At surgery Poorly 
differentiated 
papillary thyroid 
carcinoma
JV Excision JV Unknown
F 32 No Venography Papillary 
carcinoma
BV, JV Resection JV, 
shaved off BV131I
Alive 4 yrs 10 
month
F 36 No At surgery Poorly 
differentiated 
papillary 
carcinoma
JV Excision JV 
Thrombectomy 
131I
Alive 2 yrs 6 
months
F 36 No CT Poorly 
differentiated 
thyroid 
carcinoma
JV Radical neck 
dissection
Died 4 days 
post-operatively
M 60 Yes CT Undifferentiated 
papillary thyroid 
carcinoma
JV Excision JV Died 1 day post-
operatively
Koike (2002) 
[17]
F 26 No At surgery Papillary cell 
carcinoma
BV, SVC Thrombectomy Alive 8 months
Sugimoto (2006) 
[18]
M 61 Yes CT, MRI, 
Venography
Poorly 
differentiated 
papillary cell 
carcinoma
BV, SVC, RA Excision BV, 
SVC 
Thrombectomy 
Vein graft
Died 12 days 
post-operatively 
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tumour registry of patients with thyroid cancer based on a
confirmed histological report of thyroid malignancy. All
clinical information at the time of presentation and at fol-
low-up is entered at the time of consultation. We searched
for patients with clinical, radiological and pathological
evidence of occlusion of the great veins in the neck.
Patients had to have a minimum follow-up of 2 years after
initial treatment so as to assess the course of their disease
following treatment. Patient records were reviewed with
respect to clinical presentation, pathological features,
treatment, recurrence and survival.
A Medline literature search was performed using the
MeSH terms "superior vena cava obstruction" or "great
vein infiltration" or "venous occlusion" and "thyroid can-
cer." We searched from 1980 since before that time arti-
cles were not consistently linked to MeSH terminology.
We have included reports dating before 1980 if these were
detailed in the articles uncovered in the search.
Case presentations
Case 1
An 81 year old lady was referred for a painless mass arising
in the right side of her neck of 4 month's duration. Cytol-
ogy suggested follicular carcinoma. A staging computed
tomography (CT) scan of the thorax performed pre-oper-
atively showed a large smooth defect in the right brachio-
cephalic vein (Fig 1a). The right internal jugular vein (IJV)
was completely blocked (Fig 1b) whilst thrombus
extended and partially occluded the superior vena cava
(SVC) (Fig 1c). At surgery there was evidence of tumour
infiltration into the strap muscles extending up to the
right submandibular gland and right IJV which was com-
pletely occluded. Total thyroidectomy and resection of the
IJV were performed. Following surgery, she developed
oedema of the face, neck, arms and bilateral breast
engorgement. She was fully anticoagulated because a
venous thrombus occluding the SVC could not be
excluded. Histopathology confirmed that the IJV was infil-
trated by multicentric follicular carcinoma. The cut end of
the vein contained tumour. She was treated with ablative
radioiodine (3GBq) plus radical dose external beam radi-
otherapy (EBRT) to the neck and superior mediastinum
(total dose: 60 Gy). A post-ablation scan revealed streaky
uptake of 131I within the right brachiocephalic vein
extending to the superior vena cava (SVC) consistent with
tumour thrombus (Figure 2a). Over the following 4 years,
she received a total dose of 30GBq and repeat 131I scan-
ning showed reduced uptake in the SVC (Figure 2b). Her
symptoms had largely resolved.
Sixty four months after diagnosis she presented with
diplopia and non iodine-avid skull metastases. She
received palliative external beam radiotherapy (35Gy in
15 fractions). Her diplopia disappeared but she finally
succumbed to progressive metastatic disease 2 months
later.
Case 2
A lady aged 59 presented with a 9 cm right sided painless
neck mass and right recurrent laryngeal palsy. A magnetic
resonance (MR) scan of the neck performed by the refer-
ring physician showed a mass with high signal intensity
arising from the right lobe of the thyroid, displacing the
trachea and encasing the right IJV. Right cervical lymph
nodes were enlarged from levels 2–4. At operation a
highly vascular tumour was present extending down into
the superior mediastinum, compressing and displacing
the IJV and right brachiocephalic vein. Total thyroidec-
tomy and neck dissection were performed with sacrifice of
the IJV because of extensive encasement by tumour.
Pathology revealed a widely infiltrating follicular carci-
noma of the thyroid with tumour at the resected margins.
Extensive lymphovascular and perineural invasion was
noted, with tumour extending into the resected IJV. She
received ablative 131I (3GBq) followed by a therapeutic
(Case 1) Figure 1
(Case 1).1a CT thorax showing filling defect in the right brachiocephalic vein (1) due to thrombus, while the left brachio-
cephalic vein (2) is patent and shows intense contrast enhancement. 1b CT neck showing patent left internal jugular vein with 
intense contrast enhancement due to regurgitation (3). Right internal jugular vein is not seen due to thrombus (4). 1c CT tho-
rax showing blocked superior vena cava (5) with thrombus and a rim of contrast enhancement indicating partial block.World Journal of Surgical Oncology 2008, 6:36 http://www.wjso.com/content/6/1/36
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dose of 5.8 GBq (Fig 3). Adjuvant EBRT was administered
to the both sides of the neck, encompassing the extent of
the original tumour to a total dose of 66 Gy in 33 daily
fractions.
Twelve months following presentation, she developed a
diffuse large B-cell lymphoma and was treated with
CHOP chemotherapy. The patient died of cardiac failure
but free of thyroid cancer (undetectable serum thyroglob-
ulin) and free of lymphoma 23 months after presentation.
Case 3
This 61 year old lady presented with a right sided painless
hard thyroid swelling. A right thyroid lobectomy with
right levels 3, 4 and 6 lymph node dissection was per-
formed followed by completion thyroidectomy. At opera-
tion tumour was seen to be surrounding and invading the
right IJV. Pathology revealed a 4 cm Hürthle cell carci-
noma invading the right IJV with widespread infiltration
of venules and veins (Fig 4). One of 8 lymph nodes was
positive for tumour. A post-operative isotope scan showed
no significant 131I uptake in the thyroid bed or elsewhere
so she was not offered ablative 131I. She received radical
dose EBRT to the neck and upper mediastinum. Her dis-
ease progressed and she developed brain metastases for
which she received palliative radiotherapy with good
results. She died of tumour 28 months after presentation.
Case 4
This 43 year old lady presented with a firm left sided
swelling in the neck. Staging CT and MRI of the neck were
performed to assess operability. The scans showed a mass
arising in the left lobe of the thyroid extending to the
superior mediastinum. Multiple lymph nodes were visual-
ized in the left cervical chain encasing the carotid sheath.
At operation the left lobe of the thyroid was enlarged and
adherent to the strap muscles, oesophagus and trachea,
with retrosternal extension. A tubular mass of tumour was
found to be invading the IJV and most of the associated
venous complex in the upper neck extending up the com-
mon facial vein at the margin of the mandible. Tumour
extended into the lumen of the deep lingual vein and
other veins associated with the superior thyroid pedicle.
Total thyroidectomy with clearance of lymph nodes in
levels 1,2, 3 and 4 was performed. The surgeon was able
(Case 1) Figure 2
(Case 1).2a. Post radioiodine ablation scan showing abnormal 131I accumulation in the right upper neck and thyroid bed. 
There is a linear abnormality to the right of the midline of the upper chest extending inferiorly suggestive of residual tumour in 
the SVC. 2b. Post radioiodine therapy scan showing a focus of intense 131I accumulation in the right upper mediastinum sug-
gesting tumour at the root of the SVC. Marked improvement compared with initial scan (2a).World Journal of Surgical Oncology 2008, 6:36 http://www.wjso.com/content/6/1/36
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to dissect tumour free of the trachea and oesophagus but
unable to conserve the left sternomastoid, left IJV, deep
lingual and common facial veins, all of which were sacri-
ficed. Pathology revealed a poorly differentiated follicular
thyroid carcinoma. A mass of tumour was demonstrated
in the resected IJV (Fig 5). Post-operative 131I scanning
showed intense 131I accumulation in the midline of the
neck (Fig 6).
Following surgery radical dose EBRT consisting of 46 Gy
given in 23 fractions over four and a half weeks was
administered to both sides of the neck up to the level of
the mastoid processes, followed by 20Gy to the left side of
the neck. In addition she received an ablative 131I dose of
5.5GBq followed by a further 5.6GBq therapeutic dose.
Thirty three months after presentation, she developed cav-
ernous sinus thrombosis with a tumour deposit in this
area on MRI plus multiple lung and bone metastases. She
received EBRT to the base of the skull with good sympto-
(Case 2) Figure 3
(Case 2). Radioiodine ablation scan showing a moderately sized area of accumulation to the right of midline of the lower neck 
corresponding to the internal jugular vein.World Journal of Surgical Oncology 2008, 6:36 http://www.wjso.com/content/6/1/36
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matic relief and remains asymptomatic but with disease
53 months after initial presentation.
Case 5
This 70 year old gentleman presented with hoarseness fol-
lowed by dyspnoea and progressive engorgement of neck
veins. A nodular goiter was present on examination. CT
scan revealed a bulky tumour in the thyroid bed extending
into the pre-tracheal space and down the superior medi-
astinum to the level of the tracheal bifurcation. There was
significant compression of the SVC from bulky right hilar
lymphadenopathy. Lymphadenopathy was present from
the angle of the mandible to the right supraclavicular
fossa.
Pathology revealed a high grade papillary thyroid carci-
noma with columnar cell architecture (Fig 7). He under-
went total thyroidectomy and neck dissection followed by
131I ablation.
He received 5.5GBq 131I ablation followed by a 9.2GBq
therapeutic dose. His symptoms improved initially but
within 9 months hoarseness and engorgement of veins
recurred. CT showed recurrent tumour in the neck and
serum thyroglobulin rose from undetectable (post-opera-
tively) to 4551 µg/l.
Hyper-fractionated accelerated radiotherapy to the neck
and mediastinum delivered with a total dose of 50 Gy
given in two phases: Phase 1 consisted of 40 Gy in 24 frac-
tions to the neck and mediastinum twice daily; phase 2
comprised 10Gy in 6 fractions twice daily avoiding the
spinal cord. There was some improvement in his symp-
toms and he died with locally controlled disease 26
months following presentation.
Discussion
Obstruction of venous return in the mediastinum and
neck is caused by a malignant process in up to 90% of
cases, most commonly lung cancer [4]. However, it is rare
for thyroid cancer to result in occlusion of the great veins
either by extrinsic compression or tumour invasion of the
venous wall and thrombosis. To date only 24 cases of thy-
roid cancer and invasion of mediastinal veins have been
reported as shown in Table 1[2,3,5-18]. Of these, fifteen
were treated aggressively with resection of the primary
cancer and tumour thrombectomy. Five of these patients
died within 12 days of surgery from post-operative com-
plications; eight were alive at follow-up 4–58 (median 27)
months, and outcome in two patients is not documented.
The eight patients not aggressively treated had a median
survival of 39 days following presentation.
In our series of 5 patients, all underwent total thyroidec-
tomy and neck dissection. Where tumour was encasing or
invading the jugular veins in the neck, it was resected.
Ablative and therapeutic doses of radio iodine were given
to all patients except in case 3 who had Hürthle cell carci-
noma and no significant 131I uptake. Extensive tumour
was present threatening major structures in the neck. It
was decided that a complete response to ablative radioio-
dine could not be assumed and that waiting six months
without further treatment before being able to give a ther-
apeutic dose of 131I might prove hazardous. All patients
were therefore treated with EBRT. We found a median sur-
vival of 28 months (range 23–66) and median disease free
survival of 24 months (range 9–33) as shown in Table 2.
Our patients had varying degrees of venous obstruction
ranging from radiological signs only (cases 1, 2 and 4) or
an incidental finding at surgery (case 3), to a florid SVC
occlusion syndrome (case 5). This reflects the ability of
venous collateral pathways to divert blood away from an
obstruction.
The presence of dilated veins on the neck and torso is sug-
gestive and was documented in 12 of the 24 reported cases
(Table 1). Patients may complain of breathlessness,
cough, headache and syncope. Thrombus may obstruct
flow in associated veins such as external jugular or brachi-
ocephalic veins giving rise to distinct clinical features [17].
Extension into the atria may cause sudden death in these
patients [18].
CT scanning and MRI may differentiate external compres-
sion from intraluminal tumour. Intrathoracic extension of
tumour should raise suspicion of involvement of the great
(Case 3) Figure 4
(Case 3). Hürthle cell carcinoma expanding right IJV lumen, 
with adjacent smaller tumour mass. Note cells with uniform 
round nuclei and abundant granular cytoplasm (haematoxylin 
and eosin × 200).World Journal of Surgical Oncology 2008, 6:36 http://www.wjso.com/content/6/1/36
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vessels and should alert the surgeon to the possibility that
a sternotomy or cardiopulmonary bypass may be
required. In case 1, tumour thrombus was suggested by a
smooth defect in the brachiocephalic vein extending into
the SVC. A surrounding hypodense rim of blood clot may
be also be demonstrated by CT. External compression was
also correctly identified by CT in case 5. Encasement but
not vascular invasion was seen on MRI in case 2. However
in case 4, neither CT nor MRI demonstrated occlusion of
the left IJV, deep lingual and common facial veins.
Colour Doppler ultrasound and venography may be help-
ful especially for excluding thrombus in the upper extrem-
ities but the SVC may be obscured by osseous structures or
lung parenchyma [19]. CT venography has the advantage
over digital subtraction venography in its ability to evalu-
ate the proximal extent of obstruction or thrombosis [20].
Gallium-67 scintigraphy has been used successfully in
diagnosing tumour thrombus in a patient with anaplastic
thyroid cancer [21].
(Case 4) Figure 5
(Case 4).5a) Large, partially endothelialised direct extension of follicular carcinoma, attached to vessel wall (haematoxylin and 
eosin × 200). 5b) Follicular carcinoma abutting wall of internal jugular vein (haematoxylin and eosin × 40).
(Case 5) Figure 7
(Case 5).7a) Papillary carcinoma: papillary clusters of cells replacing large vessel with similar invasion of smaller vessels, top 
right (haematoxylin and eosin × 100). 7b) Papillary carcinoma higher magnification: papillae with fibrovascular cores, lined by 
crowded cells with nuclear clearing and occasional grooving (haematoxylin and eosin × 400).World Journal of Surgical Oncology 2008, 6:36 http://www.wjso.com/content/6/1/36
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Complete resection is recommended where possible to
reduce tumour burden. The presence of massive intravas-
cular invasion should not be a contraindication for resec-
tion to palliate impending SVC obstruction [3]. Without
surgery the prognosis is bleak and death follows from
tumour embolism or obstruction of the right atrium [18].
During segmental vein resection, the involved vein is
ligated before handling to prevent tumour embolisation
[9]. Surgery should be complemented with radioiodine in
iodine-avid tumours as this may reduce the risk of recur-
rence.
The value of EBRT in the management of thyroid cancer
remains controversial because published data are conflict-
ing and there are no prospective randomised controlled
trials. There is good evidence that EBRT improves local
control in patients with gross macroscopic residual dis-
ease following surgery [22]. In patients with residual
microscopic disease postoperatively, a beneficial effect of
(Case 4) Figure 6
(Case 4). Ablation radioiodine scan showing a large area of accumulation in the midline of the neck with a further small low-
grade focus inferior in the midline, suggestive of remnant thyroid or tumour tissue.World Journal of Surgical Oncology 2008, 6:36 http://www.wjso.com/content/6/1/36
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EBRT was reported in patients with papillary thyroid can-
cer [23]. We recommend EBRT for all patients with known
microscopic disease following surgery if older than 45
years or if tumour is poorly differentiated, and for known
macroscopic disease [24]. It is also recommended for
advanced and recurrent Hurthle cell carcinoma as this
tumour takes up iodine infrequently [25]. The maximum
dose of EBRT with acceptable toxicity was 60 Gy over 6
weeks in this series similar to that previously reported
[26]. Venous obstruction by thyroid cancer occasionally
responds dramatically to EBRT [27].
The circulation is well compensated by collaterals in
patients with long standing venous obstruction and sur-
gery is generally well tolerated. Stenting as a palliative
therapy can be considered if surgery is not feasible [28].
Patients with rapidly progressing compression symptoms
should be offered symptomatic treatment in the form of
bed rest, oxygen and corticosteroids.
Conclusion
Our small number of patients makes it impossible to pro-
pose a treatment based on evidence. A prospective ran-
domised trial comparing different treatment modalities
would provide reliable evidence but this is not feasible
with such a rare condition. Despite this difficulty, multi-
modality therapy which includes surgery, radioiodine and
external beam radiotherapy appears to offer the best
chance of prolonging survival.
Abbreviations
SVC – Superior vena cava IJV – Internal jugular vein EBRT
– External beam radiotherapy 131I – Radioiodine therapy
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